Elite Pharmaceuticals, Inc. (OTCMKTS:ELTP) Short Interest Up 7.6% in December

Elite Pharmaceuticals, Inc. (OTCMKTS:ELTP - Get Free Report) saw a large increase in short interest in December. As of December 15th, there was short interest totalling 2,717,700 shares, an increase of 7.6% from the November 30th total of 2,526,500 shares. Based on an average trading volume of 3,098,300 shares, the days-to-cover ratio is currently 0.9 days.

Elite Pharmaceuticals Trading Down 3.4 %

Shares of ELTP stock traded down $0.02 during mid-day trading on Wednesday, reaching $0.54. 759,559 shares of the stock traded hands, compared to its average volume of 1,663,525. The company has a market cap of $578.04 million, a price-to-earnings ratio of -54.11 and a beta of 0.25. The company has a quick ratio of 2.42, a current ratio of 3.52 and a debt-to-equity ratio of 0.10. The stock's fifty day simple moving average is $0.56 and its two-hundred day simple moving average is $0.38. Elite Pharmaceuticals has a 1-year low of $0.12 and a 1-year high of $0.75.

Elite Pharmaceuticals Company Profile

Elite Pharmaceuticals, Inc, a specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals. The company operates in two segments, Abbreviated New Drug Applications for Generic Pharmaceuticals and New Drug Applications for Branded Pharmaceuticals.